| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |